Suchergebnisse - "Bailey, Lucy"

PubPharm (38)

1

Mind-body therapies adjuvant to chemotherapy improve quality of life and fatigue in top cancers : A systematic review and meta-analysis

enthalten in: Complementary therapies in clinical practice | 2024

von Bailey, L. | Morris, M.

2

Advancing Health Equity Knowledge, Attitudes, and Beliefs Within a National Health Nonprofit Organization

enthalten in: Journal of public health management and practice : JPHMP | 2023

von Rabinowitz Bailey, L. | Ubri, P. | Stephens, R. | +4

3

A single-centre, observational study to evaluate immune response to Covid-19 vaccines in immunocompromised patients with haematological disorders (COVAC-IC)

enthalten in: bioRxiv.org | 2022

von Chandra, D. | O’ Mara, L. | Bailey, L. | +21

4

Intense Pulsed Light : A Therapeutic Option for Patients With Rosacea-Related Dry Eye and Blepharospasm

enthalten in: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society | 2022

von Monterastelli, A. | Bailey, L. | Cockerham, K.

5

The poor relation : health education in English schools

enthalten in: Journal of the Royal Society of Medicine | 2022

von Lowry, C. | Rees, J. | Gregson, D. | +4

6

Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy : A multicenter study

enthalten in: American journal of ophthalmology case reports | 2021

von Sears, C. | Wang, Y. | Bailey, L. | +5

7

The MUK eight protocol : a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor

enthalten in: Trials | 2020

von Hinsley, S. | Walker, K. | Sherratt, D. | +13

8

The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor

enthalten in: Trials | 2020

von Hinsley, S. | Walker, K. | Sherratt, D. | +12

9

The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor

enthalten in: Trials | 2020

von Hinsley, S. | Walker, K. | Sherratt, D. | +12

10

Visual Outcomes of Patients With Retrobulbar Hemorrhage Undergoing Lateral Canthotomy and Cantholysis

enthalten in: Ophthalmic plastic and reconstructive surgery | 2019

von Bailey, L. | van Brummen, A. | Ghergherehchi, L. | +3